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The COVID-19 pandemic is likely an epic reshaping of
human behavior across the globe. Beyond our knowl-
edge of previous pandemics and infections, COVID-
19 demanded extraordinary changes in our lifestyle.
The virus spread rapidly across the globe due to its
high transmissibility, and the extraordinary death toll
was unprecedented. In the early stages of this pan-
demic, there was a sense of powerlessness leading us
to isolation from public gathering. Under the lead-
ership of the World Health Organization (WHO), the
Centers for Disease Control and Prevention (CDC), and
other organizations, the predominant response was to
use preventive measures, including social distancing,
hand washing and face masks. These measures have
been very effective in preventing infection and contain-
ing the spread of infection in previous epidemics and
pandemics. Ongoing protective measures are critical to
mitigate the pandemic; however, controversies persist
concerning the use of face masks as a protection mea-
sure against COVID.
One of the greatest privileges of today’s world is the
right to have our own opinion on any finding and
to share it through digital media. Diversity of opin-
ion makes our world rich with ideas; however, some
opinions—well-intentioned or otherwise—can result in
suffering and loss of lives.
Constructive scientists recognize the limitations of our
knowledge and develop hypotheses in efforts to ex-
pand it. Unfortunately, in the time of the infodemic,
not all medical research—particularly articles posted
as preprints—undergo rigorous scientific scrutiny. Our
journal previously published our position on preprints
as potentially unreliable sources of knowledge.[1] Fur-
thermore, traditional and social media are being used
to spread misinformation and disinformation despite
the efforts of infodemic surveillance organizations. In
this note, we would like to address the controversy re-
garding whether the use of face masks by people in the
community prevents infection and the spread of infec-
tion to others.
The CDC recommends the use of a face mask consisting
of two or more layers of fabric for those not fully vac-
cinated or who have a weak immune system; masks
are universally recommended (regardless of vaccina-
tion or immune status) in indoor public places and in
public transportation to mitigate the spread of the Delta
variant of SARS-CoV-2. For these purposes, the U.S.
Food & Drug Administration defines a face mask as
“a mask, with or without a face shield, that covers the
user’s nose and mouth and may or may not meet fluid
barrier or filtration efficiency levels”.[2] In the case of
non-medical face masks, filtration efficacy is variable.
An important point for clarification is the mask filtra-
tion efficiency for particles including the SARS-CoV-2
virus. Typically, the virus is transmitted through the air
by droplets—particles greater than 5 µm in diameter—
however, it can also be transmitted in smaller particles
(<1 µm). Filtration efficiency is the percentage of par-
ticles blocked by the mask. As a reference, medical
masks are certified by the American Society for Testing
and Material (ASTM) International with an efficiency
≥95% (Level 1) or ≥98% (Levels 2 and 3) for particles
0.1 µm in diameter.[3]
What does the current literature tell us?
Filtration efficiency
Van der Sande et al. reported the inward filtration effi-
ciency for a 1-layer tea towel at 55–77% and outward at
17% for 0.02–1 µm particles.[4] The low outward effi-
ciency could be explained by the 1-layer composition
and the fact that particles are expelled from the up-
per respiratory tract and mouth, which are high pres-
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sure spaces. Dato et al. reported an efficiency >90%
for multilayer homemade masks. Overall, if we follow
the CDC recommendation to use a ≥2-layer fabric face
mask, substantial protection is expected for the user, as
well as substantial mitigation of viral spread.[5]
Effectiveness of mask use
The effectiveness of face mask use against past and
present pandemics is well-attested in the literature. The
following is a summary of the findings of five system-
atic reviews and meta-analyses on the subject.
In 2020, few studies of mask use against COVID-19 had
been published; evidence primarily consisted of stud-
ies concerning other coronaviruses and other respira-
tory pathogens. In June 2020, Chu et al. found that
across six studies, persons wearing face masks were
at one-third the risk of infection from SARS-CoV and
MERS-CoV, Betacoronaviruses similar to SARS-CoV-
2, compared to those with uncovered faces (adjusted
odds ratio [OR] 0.33, 95% confidence interval [CI] 0.17–
0.61, I2=76%).[6] Liang et al. (July 2020) similarly found
that across 21 studies, including one on SARS-CoV-2,
face mask users were at 35% the risk of infection from
respiratory viruses compared to those with uncovered
faces (pooled OR 0.35, 95% CI 0.24–0.51, I2=60%).[7]
In subgroup analyses, the OR [95% CI] for healthcare
workers across 12 studies was 0.20 [0.11–0.37] and for
non-healthcare workers across eight studies was 0.53
[0.36–0.79].
By 2021, richer literature on mask use against SARS-
CoV-2 specifically was available for meta-analysis. In
January 2021, Tabatabaeizadeh et al. demonstrated a
significant reduction in SARS-CoV-2 infection risk with
face mask use across four studies (pooled relative risk
[RR] 0.12, 95% CI: 0.06–0.27, P<0.001).[8] In a meta-
analysis by Hemmer et al. (February 2021) of 29 stud-
ies on SARS-CoV, MERS-CoV, and SARS-CoV-2, mask
use was associated with one-third odds of infection
(adjusted OR 0.04, 95% CI: 0.004–0.3 [N95 respirators]
and 0.33, 95% CI 0.17–0.61 [other masks]).[9] Li et al.
(July 2021) similarly found that across six studies, wear-
ing a mask was associated with significantly reduced
odds of COVID-19 infection (OR 0.38, 95% CI: 0.21–
0.69, I2=54.1%).[10]
Effectiveness of government-mandated mask use
A 2021 cross-sectional study found that a 10% increase
in self-reported mask use was associated with a more
than three-fold increase in odds of transmission control
(multivariate logistic regression model with 10-point
extrapolation, adjusting for confounders, physical dis-
tancing, and a time trend).[11] However, the study
also found no statistically significant change in aver-
age mask usage as a result of government mandate. By
contrast, MacIntyre et al. observed a statistically signifi-
cant association between mask mandates and mask use
in univariate regression analysis (P<0.001).[12]
In a 2020 ecological study, Fang et al. found that coun-
ties in states with face mask mandates were at signif-
icantly less risk of COVID-19 incidence, with an ad-
justed risk ratio of 0.8462 (95% CI: 0.7592–0.9433).[13]
This association was observed during the second surge
(May 28–September 12, 2020), but not during the first
surge (up to May 28, 2020).
A study of SARS-CoV-2 spread prior to the start of
vaccination found that the rapid implementation of
mask mandates was associated with lower rates of in-
fection.[14] States that implemented mask mandates
3–6 months after the start of their respective SARS-
CoV-2 epidemic (defined as ≥50 cases present in the
state) had an infection rate 1.61 times higher than
states that implemented a mask mandate within one
month (adjusted rate ratio 1.61 (95% CI: 1.23–2.10),
P<0.001). States that implemented mask mandates af-
ter six months or did not implement mask mandates
had an infection rate 2.16 times higher than states that
implemented a mask mandate within one month (ad-
justed rate ratio 2.16 (95% CI: 1.64–2.88, P<0.0001).
Conclusion
Despite the many medical resources at our disposal,
the landscape of the COVID-19 epidemic looks like a
disastrous battlefield in the US. As of August 25, 2021,
there have been 38,077,814 confirmed cases of COVID-
19 and 630,840 deaths, while only 51.6% of the US pop-
ulation is fully vaccinated.[15, 16] The most recent com-
plete epidemiological week (August 15–21, 2021) saw
nearly a million new cases of COVID-19 reported to the
CDC, the greatest surge since 1.7 million were reported
at the beginning of 2021 (Figure 1). The surge is largely
among the unvaccinated and demands extraordinary
measures to contain it. Regardless of the relatively lim-
ited data and lack of optimal randomized controlled tri-
als to confirm the benefit of face masks against COVID-
19, the available data indicate a moderate protection
that is crucial to protect our communities. We strongly
recommend the use of face masks to the public in line
with the recommendations of the CDC and the Infec-
tious Diseases Society of America.
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Figure 1. Cases of COVID-19 reported to the Centers for Disease Control and Prevention (CDC) per week.
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